Alkyl sulfonic acide hydrazides: Synthesis, characterization, computational studies and anticancer, antibacterial, anticarbonic anhydrase II (hCA II) activities

dc.contributor.authorOzdemir, Ummuhan O.
dc.contributor.authorIlbiz, Firdevs
dc.contributor.authorGunduzalp, Ayla Balaban
dc.contributor.authorOzbek, Neslihan
dc.contributor.authorGenc, Zuhal Karagoz
dc.contributor.authorHamurcu, Fatma
dc.contributor.authorTekin, Suat
dc.contributor.authorHamurcu, Fatma
dc.date.accessioned2025-10-18T10:10:37Z
dc.date.created2015
dc.date.issued2015
dc.departmentFakülteler, Fen Fakültesi, Moleküler Biyoloji ve Genetik Bölümü
dc.description.abstractMethane sulfonic acide hydrazide, CH3SO2NHNH2 (1), ethane sulfonic acide hydrazide, CH3CH2SO2NHNH2 (2), propane sulfonic acide hydrazide, CH3CH2CH2SO2NHNH2 (3) and butane sulfonic acide hydrazide, CH3CH2CH2CH2SO2NHNH2 (4) have been synthesized as homologous series and characterized by using elemental analysis, spectrophotometric methods (H-1-C-13 NMR, FT-IR, LC-MS). In order to gain insight into the structure of the compounds, we have performed computational studies by using 6 311G(d, p) functional in which B3LYP functional were implemented. The geometry of the sulfonic acide hydrazides were optimized at the DFT method with Gaussian 09 program package. A conformational analysis of compounds were performed by using NMR theoretical calculations with DFT/B3LYP/6 311++G(2d, 2p) level of theory by applying the (GIAO) approach. The anticancer activities of these compounds on MCF-7 human breast cancer cell line investigated by comparing IC50 values. The antibacterial activities of synthesized compounds were studied against Gram positive bacteria; Staphylococcus aureus ATCC 6538, Bacillus subtilis ATCC 6633, Bacillus cereus NRRL-B-3711, Enterococcus faecalis ATCC 29212 and Gram negative bacteria; Estherichia coli ATCC 11230, Pseudomonas aeruginosa ATCC 15442, Klebsiella pneumonia ATCC 70063 by using the disc diffusion method. The inhibition activities of these compounds on carbonic anhydrase II enzyme (hCA II) have been investigated by comparing IC50 and Ki values. The biological activity screening shows that butane sulfonic acide hydrazide (4) has more activity than the others against tested breast cancer cell lines MCF-7, Gram negative/Gram positive bacteria and carbonic anhydrase II (hCA II) isoenzyme. (C) 2015 Elsevier B.V. All rights reserved.
dc.description.sponsorshipGazi University [05/2010-92]
dc.description.sponsorshipThis research was supported by Gazi University Research Fund under Project No 05/2010-92. We thank Ankara University, Faculty of Pharmacy. Central Labs, for allocation of time at the Mass Spectra and Elemental Analyses.
dc.identifier.doi10.1016/j.molstruc.2015.07.054
dc.identifier.endpage474
dc.identifier.issn0022-2860
dc.identifier.issn1872-8014
dc.identifier.orcidOzdemir Ozmen, ummuhan/0000-0001-9161-9367
dc.identifier.orcidTekin, Suat/0000-0002-2757-1802
dc.identifier.scopus2-s2.0-84939209591
dc.identifier.scopusqualityQ2
dc.identifier.startpage464
dc.identifier.urihttps://doi.org/10.1016/j.molstruc.2015.07.054
dc.identifier.urihttps://hdl.handle.net/11772/21963
dc.identifier.volume1100
dc.identifier.wosWOS:000365361600056
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofJournal of Molecular Structure
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.relation.sdgGoal-03: Good Health and Well-Being
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzWoS_20251016
dc.subjectAlkyl Sulfonic Acide Hydrazide
dc.subjectSulfonamide
dc.subjectAnticancer
dc.subjectAntibacterial
dc.subjectAnti Carbonic Anhydrase Ii Isoenzyme
dc.subjectComputational Studies
dc.titleAlkyl sulfonic acide hydrazides: Synthesis, characterization, computational studies and anticancer, antibacterial, anticarbonic anhydrase II (hCA II) activities
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublication38c28fa3-a59e-4c80-984a-67d17a93ca93
relation.isAuthorOfPublication.latestForDiscovery38c28fa3-a59e-4c80-984a-67d17a93ca93

Dosyalar